JOAN SALLES ALVIRA-rekin lankidetzan egindako argitalpenak (7)

2021

  1. Solid-phase synthesis of imprinted nanoparticles as artificial antibodies against the C-terminus of the cannabinoid CB1 receptor: exploring a viable alternative for bioanalysis

    Microchimica Acta, Vol. 188, Núm. 11

2015

  1. Nuclear diacylglycerol lipase-α in rat brain cortical neurons: Evidence of 2-arachidonoylglycerol production in concert with phospholipase C-β activity

    Journal of Neurochemistry, Vol. 132, Núm. 5, pp. 489-503

2012

  1. Validation of an LC-ESI-MS/MS method for the quantitation of phosphodiesterase-5 inhibitors and their main metabolites in rat serum and brain tissue samples

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 70, pp. 529-533

2008

  1. Simultaneous determination of citalopram, fluoxetine and their main metabolites in human urine samples by solid-phase microextraction coupled with high-performance liquid chromatography

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 46, Núm. 4, pp. 763-770

2007

  1. Determination of fluoxetine, norfluoxetine and their enantiomers in rat plasma and brain samples by liquid chromatography with fluorescence detection

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 852, Núm. 1-2, pp. 519-528

2002

  1. Determination of methylarginines in human plasma by HPLC with pre-column derivatization using naphthalenedicarboxaldehyde as fluorogenic agent

    Journal of Separation Science, Vol. 25, Núm. 10-11, pp. 665-670

2001

  1. Determination of catecholamines and their metabolites in human plasma using liquid chromatography with coulometric multi-electrode cell-design detection

    Analytica Chimica Acta, Vol. 444, Núm. 2, pp. 211-221